Evidence map›Paper›PMID 32162826›Full record

ArticleThe oncologist2020

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

Marsha Reyngold, Kathryn A Winter, William F Regine, Ross A Abrams, Howard Safran, John P Hoffman, Rex B Mowat, John P Hayes, Ivan L Kessel, Thomas DiPetrillo and 14 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The oncologist, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00003216 (A Phase III Study of Pre and Post Chemoradiation 5-FU vs. Pre and Post Chemoradiation Gemcitabine for Postoperative Adjuvant Treatment of Resected Pancreatic Adenocarcinoma), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00003216 phase3completednot on this map

A Phase III Study of Pre and Post Chemoradiation 5-FU vs. Pre and Post Chemoradiation Gemcitabine for Postoperative Adjuvant Treatment of Resected Pancreatic Adenocarcinoma

TypeinterventionalSponsorRadiation Therapy Oncology GroupRan1998Enrolled518ConditionsPancreatic CancerArmsfluorouracil, gemcitabine hydrochloride, radiation therapy
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Marital status and survival in laryngeal squamous cell carcinoma patients: a multinomial propensity scores matched study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Effects of Marital Status on Prognosis in Women with Infiltrating Ductal Carcinoma of the Breast: A Real-World 1: 1 Propensity-Matched Study.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 20 institutions in 2 countries.

Marsha ReyngoldMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Kathryn A WinterNRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania, USA.
William F RegineUniversity of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland, USA.
Ross A AbramsRush University Medical Center, Chicago, Illinois, USA.
Howard SafranRhode Island Hospital, Providence, Rhode Island, USA.
John P HoffmanFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Rex B MowatToledo Community Hospital Oncology Program, Community Clinical Oncology Program, Toledo, Ohio, USA.
John P HayesNorthwestern Memorial Hospital, Chicago, Illinois, USA.
Ivan L KesselUniversity of Texas Medical Branch, Galveston, Texas, USA.
Thomas DiPetrilloLifespan Cancer Institute, Providence, Rhode Island, USA.
Samir NarayanMichigan Cancer Research Consortium, Grand Rapid, Michigan, USA.
Yuhchyau ChenUniversity of Rochester, Rochester, New York, USA.
Edgar Ben-JosefUniversity of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA.
Guila DelouyaCentre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
John H SuhCleveland Clinic Foundation, Cleveland, Ohio, USA.
Joshua MeyerFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Michael G HaddockMayo Clinic, Rochester, New York, USA.
Marvin FeldmanSinai Hospital of Baltimore, Baltimore, Maryland, USA.
Rakesh GaurKansas City Community Clinical Oncology Program, Prairie Village, Kansas, USA.
Kathleen YostGrand Rapids Community Clinical Oncology Program, Grand Rapids, Michigan, USA.
Richard A PetersonSt. Francis Regional Medical Center, Shakopee, Minnesota, USA.
David L SherrThe Brooklyn Hospital Center, New York, New York, USA.
Jennifer MoughanNRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania, USA.
Christopher H CraneMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Fox Chase Cancer Center · USMemorial Sloan Kettering Cancer Center · USNRG Oncology · USBrooklyn Hospital Center · USCentre Hospitalier de l’Université de Montréal · CACleveland Clinic · USCommunity Hospital · USGrand Rapids Community College · USLifespan · USMayo Clinic · USMichigan Cancer Research Consortium · USNorthwestern Memorial Hospital · USRhode Island Hospital · USRush University Medical Center · USSinai Hospital · USSt. Francis Regional Medical Center · USThe University of Texas Medical Branch at Galveston · USUniversity of Maryland, Baltimore · USUniversity of Pennsylvania · USUniversity of Rochester · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI James J. Dignam, GREG YOTHERS · 2014 to 2026
$146.4M
NRG Oncology NCORP Research Base-BIQSFPUG1CA189867 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Deborah Watkins Bruner, Lisa A. Kachnic · 2014 to 2026
$140.5M
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer CenterUG1CA233290 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CAROL AGHAJANIAN, Darren Feldman · 2019 to 2026
$10.2M
NCI NIH HHS P30 CA008748NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868NCI NIH HHS UG1 CA189867NCI NIH HHS UG1 CA233290
6 · The paper itself

Abstract

backgroundSeveral registry-based analyses suggested a survival advantage for married versus single patients with pancreatic cancer. The mechanisms underlying the association of marital status and survival are likely multiple and complex and, therefore, may be obscured in analyses generated from large population-based databases. The goal of this research was to characterize this potential association of marital status with outcomes in patients with resected pancreatic cancer who underwent combined modality adjuvant therapy on a prospective clinical trial. MATERIALS AND

methodsThis is an ancillary analysis of 367 patients with known marital status treated on NRG Oncology/RTOG 97-04. Survival analysis was performed using the Kaplan-Meier method and compared using the log-rank test. Multivariate analysis was performed using the Cox proportional hazards regression model.

resultsOf 367 patients, 271 (74%) were married or partnered and 96 (26%) were single. Married or partnered patients were more likely to be male. There was no association between marital status and overall survival (OS) or disease-free survival (DFS) on univariate (hazard ratio [HR], 1.09 and 1.01, respectively) or multivariate analyses (HR, 1.05 and 0.98, respectively). Married or partnered male patients did not have improved survival compared with female or single patients.

conclusionAncillary analysis of data from NRG Oncology/RTOG 97-04 demonstrated no association between marital and/or partner status and OS or DFS in patients with resected pancreatic cancer who received adjuvant postoperative chemotherapy followed by concurrent external beam radiation therapy and chemotherapy. Clinical trial identification number. NCT00003216. IMPLICATIONS FOR PRACTICE: Several population-based studies have shown an epidemiological link between marital status and survival in patients with pancreatic cancer. A better understanding of this association could offer an opportunity to improve outcomes through psychosocial interventions designed to mitigate the negative effects of not being married. Based on the results of this analysis, patients who have undergone a resection and are receiving adjuvant therapy on a clinical trial are unlikely to benefit from such interventions. Further efforts to study the association between marital status and survival should be focused on less selected subgroups of patients with pancreatic cancer.

Indexed as

Pancreatic NeoplasmsFemaleHumansMaleMarital StatusProportional Hazards ModelsProspective StudiesSurvival AnalysisMarital statusPancreatic cancerRadiation therapySurvival

Identifiers

PMID32162826
PMCPMC7066692
OpenAlexW2996280469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.